Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 234 results for "Tecfidera Treated Patients"

PML Death Reported in Patient Treated With Dimethyl Fumarate

—FDA today announced upcoming changes to the labeling of dimethyl fumarate after the death of the patient who was taking the drug for the treatment of multiple sclerosis (MS). According to FDA, the patient, a 54-year-old woman, was ... ASHP, 1 day ago
Pharma Letter

FDA adds warning to Tecfidera label after patient death

The US Food and Drug Administration has issued a warning that a patient with multiple sclerosis who was being treated with Tecfidera (dimethyl fumarate), from US biotech major Biogen Idec (Nasdaq: BIIB), developed a serious brain infection called ...
 Pharma Letter13 hours ago Tecfidera (dimethyl fumarate) by Biogen Idec: Drug Safety Communication - Case of Rare Brain Infection PML Reported  U.S. Food and Drug Administration1 day ago FDA Drug Safety Communication: FDA warns about case of rare brain infection PML with MS drug Tecfidera (dimethyl fumarate)  U.S. Food and Drug Administration1 day ago FDA green lights Lemtrada for MS  Pharmafocus1 week ago

Biogen's Tecfidera Label Updated After Rare Brain Infection Case

The label for Biogen Idec Inc. (BIIB) 's multiple sclerosis drug Tecfidera will be updated with information about a patient who died of a rare brain infection while taking the medicine, U.S. regulators said today. The drug label, which gives ...
 Bloomberg1 day ago FDA amends label of Biogen Idec's Tecfidera to warn of a case of PML  FirstWord Pharma1 day ago Why Tecfidera Drug Label Is Updated...  RTTNews.com22 hours ago FDA Orders New Label For Biogen Idec's MS Drug; Exact Sciences Announces Final Payment Decision for Cologuard®  BioMedReports1 day ago

Forward Pharma Sues Biogen Idec Over Tecfidera(R) Sales in Germany

Tecfidera® is a product containing dimethyl fumarate (DMF) as the active ingredient for the treatment of MS. It was approved by the European Commission in January 2014. Worldwide sales of Tecfidera® as reported by Biogen Idec for the previous 4 ...
 Morningstar.com1 week ago Forward Pharma Files Lawsuit Against Biogen Over Tecfidera Sales In Germany  RTTNews.com1 week ago Forward Pharma : Sues Biogen Idec Over Tecfidera(R) Sales in Germany  4 Traders1 week ago Biogen: Nothing To Worry About  Seeking Alpha4 weeks ago

Biogen Falls On Patient's Death

Biogen stock traded down 5% yesterday following the announcement that a patient administered with Tecfidera, the company's MS drug, died after developing a brain infection Page 1 of 2 Click Ticker to See live coverage Biogen Idec Inc ( ...
 Bidness Etc1 month ago Hot Biogen shares fall after Tecfidera patient dies  CNBC1 month ago Biogen falls after Tecfidera patient dies  CNBC1 month ago

Biogen Falls After Patient Taking Top-Selling Tecfidera Dies

(Updates with closing shares in third paragraph.) Oct. 22 (Bloomberg) -- Shares of Biogen Idec Inc. fell the most in seven months after the company said a patient developed a rare brain infection and died while taking its top-selling multiple ...
 Washington Post1 month ago Health Exchange: Biogen shares drop on Tecfidera patient death  Austin American Statesman1 month ago Biogen Falls After Patient on Top-Selling Drug Dies  BusinessWeek1 month ago Why Biogen Idec Stock Shares Are Getting Pummeled Today  Nasdaq1 month ago
European Medicines Agency

Inform Patients of PML Case With Tecfidera in MS

The European Medicines Agency's (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) is advising physicians to inform their patients about a fatal case of progressive multifocal leukoencephalopathy (PML) in a patient being treated with dimethyl ...
 Medscape2 weeks ago News and press releases: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 17-20 November 2014  European Medicines Agency5 days ago Highlights of EMA Pharmacovigilance unit meeting  Pharma Letter2 weeks ago
Boston Globe

Biogen Idec prices new multiple sclerosis treatment at $62,036 per year

Cambridge biotech Biogen Idec Inc. said Friday it will charge $62,036 per patient for a year's treatment with its newly approved multiple sclerosis drug Plegridy. The list price of Plegridy, a new type of injectable drug that treats adults with the ...
 Boston Globe1 month ago Biogen Idec Announces Strides In Clinical Studies For MS Treatments  Bioresearch Online2 months ago Biogen Idec announces encouraging data from Phase III multiple sclerosis study  Individual.com2 months ago

U.S. Claims Data Show That Biogen Idec's Tecfidera Captured Nearly Half of Second-Line Share Among Newly Diagnosed Multiple Sclerosis Patients

BURLINGTON, Mass. , Nov. 24, 2014 /PRNewswire/ --Decision Resources Group finds that, according to U.S. patient-level claims data, Biogen Idec's Tecfidera, the third-to-market oral disease modifying therapy (DMT) for multiple sclerosis (MS), ...
 Crawford Financial Planning2 days ago
Bidness Etc

Why Has Biogen (BIIB) Stock Been Trading Down?

Biogen stock has been falling due to patent issues and negative sentiments regarding the death of a patient who had been using Tecfidera. However, the company's pipeline drugs show potential Page 1 of 2 Click Ticker to See live coverage ...
 Bidness Etc5 days ago EMA review for Biogen Idec's haemophilia A therapy  Pharmafocus3 weeks ago Company Update (NASDAQ:BIIB): Biogen Idec and Sobi Announce European Medicines Agency Validates ELOCTA (rFVIIIFc) Marketing Authorization Application for Review  Jutia Group3 weeks ago Is Biogen Idec Inc. in Trouble?  Motley Fool1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less